PINK:GRCK
Delisted
Grey Cloak Tech, Inc Stock News
$0.0366
+0 (+0%)
At Close: May 27, 2022
Grey Cloak Tech Fuel4Thought™ Migraine Formula Results Published in World Journal of Advanced Research and Reviews
08:30am, Thursday, 14'th Jan 2021
Fuel4Thought™ proprietary formulation pilot study reduced the number of Migraine episodes by 39% and the average duration by 61% Fuel4Thought™ proprietary formulation pilot study reduced the numbe
Emerging Markets Report: Forty Million Reasons
07:44am, Tuesday, 05'th Jan 2021
An Emerging Markets News Commentary An Emerging Markets News Commentary
Grey Cloak Tech Completes Successful Pilot Study on its Fuel4Thought™ Migraine Formula with Positive Results
08:18am, Tuesday, 22'nd Dec 2020
Fuel4Thought™ proprietary Migraine formulation is similar to their recently released Brain Booster, but scientifically designed to try and provide millions of sufferers a natural solution.
Emerging Markets Report: Doctor's Orders
10:34am, Wednesday, 16'th Dec 2020
An Emerging Markets News Commentary An Emerging Markets News Commentary
Grey Cloak Tech Inc. Subsidiary BergaMet NA™ Announces Sales Agreement with Major Key Account, Xymogen®
08:30am, Tuesday, 15'th Dec 2020
Xymogen® is a leading manufacturer and distributor of clinical grade nutraceuticals and ranked among the nation's fastest-growing privately held companies Xymogen® is a leading manufacturer and dist
Grey Cloak Tech Releases Study of Fuel4Thought Brain Booster
06:30am, Tuesday, 08'th Dec 2020
Fuel4Thought™ Brain Booster Provides Astounding Brain Activation Improvement of 49% with Its Revolutionary 2.5 oz Formulation with Zero Caffeine, Zero Sugar and Zero Crash
